Table 5.
Baseline | T2 | ||||||
---|---|---|---|---|---|---|---|
N | Median | Range | N | Median | Range | p-value | |
Intrinsic self-concordance | |||||||
Quality control cohort | 80 | 3.0 | 3.0 | 84 | 3.0 | 3.0 | 0.139 |
Group 1: remained RA | 20 | 3.66 | 2 | 19 | 3.33 | 3 | 0.145 |
Group 1: remained IR/IA | 21 | 2.67 | 2.67 | 23 | 2.33 | 3.0 | 0.550 |
Group 2: activated | 30 | 2.67 | 3 | 33 | 3.0 | 2.67 | 0.002 ** |
Group 3: inactivated | 9 | 3.0 | 1.67 | 9 | 2.67 | 1.67 | 0.327 |
Extrinsic self-concordance | |||||||
Quality control cohort | 80 | 1.5 | 2.0 | 84 | 1.33 | 3.0 | 0.157 |
Group 1: remained RA | 20 | 1.67 | 1.67 | 19 | 1.0 | 0.67 | 0.007 ** |
Group 1: remained IR/IA | 21 | 1.67 | 1.33 | 23 | 1.33 | 2.0 | 1.00 |
Group 2: activated | 30 | 1.67 | 2.0 | 33 | 1.67 | 3.0 | 0.632 |
Group 3: inactivated | 9 | 1.0 | 1.33 | 9 | 1.33 | 1.0 | 0.595 |
Introjected self-concordance | |||||||
Quality control cohort | 80 | 2.67 | 3.0 | 84 | 2.67 | 3.0 | 0.410 |
Group 1: remained RA | 20 | 2.83 | 2.67 | 19 | 2.33 | 2.33 | 0.059 |
Group 1: remained IR/IA | 21 | 3.0 | 2.67 | 23 | 3.0 | 3.0 | 0.674 |
Group 2: activated | 30 | 2.67 | 2.67 | 33 | 2.67 | 3.0 | 0.082 |
Group 3: inactivated | 9 | 2.5 | 2.0 | 9 | 3.0 | 2.33 | 0.054 |
Identified self-concordance | |||||||
Quality control cohort | 80 | 4.0 | 1.67 | 83 | 4.0 | 2.33 | 0.957 |
Group 1: remained RA | 20 | 4.0 | 1 | 19 | 4.0 | 1.33 | 0.617 |
Group 1: remained IR/IA | 21 | 3.67 | 1.33 | 23 | 3.67 | 2.33 | 0.679 |
Group 2: activated | 30 | 4.0 | 1.67 | 32 | 4.0 | 1.33 | 0.916 |
Group 3: inactivated | 9 | 3.67 | 1.33 | 9 | 3.67 | 1.0 | 0.589 |
Barriers | |||||||
Quality control cohort | 82 | 1.87 | 1.37 | 86 | 1.71 | 1.74 | 0.005 ** |
Group 1: remained RA | 20 | 1.53 | 1.2 | 19 | 1.47 | 1.0 | 0.073 |
Group 1: remained IR/IA | 22 | 1.97 | 1.0 | 24 | 1.84 | 1.2 | 0.661 |
Group 2: activated | 31 | 1.90 | 1.4 | 34 | 1.68 | 1.7 | 0.006 ** |
Group 3: inactivated | 9 | 1.95 | 1.1 | 9 | 2.05 | 1.1 | 0.484 |
Counterstrategies | |||||||
Quality control cohort | 82 | 8.0 | 12.0 | 86 | 8.0 | 15.0 | 0.072 |
Group 1: remained RA | 20 | 11.5 | 10.0 | 19 | 9.0 | 10.0 | 0.041 * |
Group 1: remained IR/IA | 22 | 8.0 | 12.0 | 24 | 5.50 | 13.0 | 0.004 ** |
Group 2: activated | 31 | 8.0 | 11.0 | 34 | 9.0 | 15.0 | 0.061 |
Group 3: inactivated | 9 | 8.0 | 9.0 | 9 | 7.0 | 10.0 | 0.306 |
Social support | |||||||
Quality control cohort | 82 | 2.14 | 2.86 | 87 | 2.29 | 2.86 | 0.742 |
Group 1: remained RA | 20 | 2.07 | 2.57 | 20 | 2.43 | 2.43 | 0.549 |
Group 1: remained IR/IA | 22 | 2.29 | 2.86 | 24 | 2.00 | 2.43 | 0.185 |
Group 2: activated | 31 | 2.14 | 2.14 | 34 | 2.43 | 2.86 | 0.592 |
Group 3: inactivated | 9 | 1.86 | 2.14 | 9 | 2.0 | 1.86 | 0.635 |
RA, regularly active; IA, irregularly active; I, inactive. N = numbers of available behavioral model results per group at respective timepoint. Data are presented as median and range. **p < 0.01, *p < 0.05, p, McNemar-Test.